Top Companies in the Photodynamic Therapy Market & Their Offerings
| Companies | Headquarters | Offerings |
| Galderma S.A. | Switzerland | Focused solutions, including PDT treatments for actinic keratosis and acne, with a strong presence in aesthetic and therapeutic skincare. |
| Sun Pharmaceutical Industries Ltd. | India | Broad portfolio of specialty and generic drugs, including dermatology products and photosensitizing agents used in PDT. |
| Biofrontera | Germany | Specializes in PDT with products like aminolevulinic acid-based therapies for skin conditions such as actinic keratosis. |
| Novartis AG | Switzerland | Innovative pharmaceuticals, including oncology and dermatology therapies, with involvement in light-based and targeted treatments. |
| Bausch Health Companies Inc. | Canada | Dermatology and specialty pharma products, including treatments relevant to skin conditions addressed by PDT. |
| Quest Pharmatech Inc. | Canada | Focuses on immunotherapy and oncology research, with development of novel therapies that complement PDT approaches. |
What are the Recent Developments in the Photodynamic Therapy Market?
- In September 2025, Biofrontera Inc. completed its Phase 3 clinical trial for Ameluz® topical gel used in photodynamic therapy, marking the final patient’s participation. The study focused on evaluating its effectiveness in treating actinic keratosis on areas such as the neck, trunk, and extremities.
- In September 2025, Soligenix expanded its European Medical Advisory Board by adding leading dermatology and oncology experts. This move aims to strengthen clinical guidance and research efforts for cutaneous T-cell lymphoma, while supporting the advancement of its photodynamic therapy and other targeted treatments for rare skin lymphomas.
Supply Chain Analysis Top Vendors in the Photodynamic Therapy Market & Their Offerings
R&D
- Research and development in photodynamic therapy is centered on improving treatment precision by increasing tumor targeting, addressing oxygen limitations in tissues, and enhancing light penetration for better therapeutic outcomes. These advancements aim to expand its effectiveness in cancer and infectious disease management.
- Key players: Pfizer, Novartis, Sun Pharmaceutical Industries, and Biofrontera.
Clinical Trials
- Clinical trials in photodynamic therapy are focused on treating different cancers and pre-cancerous conditions by improving targeted tumor destruction while minimizing damage to healthy tissues through light-activated drugs. These studies aim to enhance treatment safety and effectiveness.
- Key players: Pfizer, Novartis, Amgen, and Biofrontera.
Patient Support and Services
- Patient support in photodynamic therapy mainly involves helping patients manage strong light sensitivity for a few days after treatment. It includes guidance on avoiding light exposure, use of protective measures like sunscreen and eyewear, and counseling for skin, eye, or internal conditions. Outpatient care and monitoring also ensure patient comfort and safety during and after the procedure.
- Key players: Pfizer, Novartis, Sun Pharmaceutical Industries, and Biofrontera.
Market Growth
The global photodynamic therapy market size was estimated at USD 5.42 billion in 2025 and is predicted to increase from USD 5.9 billion in 2026 to approximately USD 12.71 billion by 2035, expanding at a CAGR of 8.9% from 2026 to 2035.
Keypoints
- Company Overview
- Locations Subsidiaries/Geographic reach
- Key Executives
- Company Financials
- Patents registered
- SWOT Analysis
- Applications Catered
- Strategic collaborations
- Recent Developments
- Competitive Benchmarking